NO20074361L - Lacosamide for "add-on" therapy - Google Patents

Lacosamide for "add-on" therapy

Info

Publication number
NO20074361L
NO20074361L NO20074361A NO20074361A NO20074361L NO 20074361 L NO20074361 L NO 20074361L NO 20074361 A NO20074361 A NO 20074361A NO 20074361 A NO20074361 A NO 20074361A NO 20074361 L NO20074361 L NO 20074361L
Authority
NO
Norway
Prior art keywords
lacosamide
therapy
add
treatment
antipsychotic
Prior art date
Application number
NO20074361A
Other languages
Norwegian (no)
Inventor
Thomas Stohr
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP05001843A external-priority patent/EP1688137A1/en
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of NO20074361L publication Critical patent/NO20074361L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Foreliggende oppfinnelse er rettet mot anvendelse av en klasse av peptidforbindelser for forebyggelse, lindring og/eller behandling av en sykdom som behandles med antipsykotiske midler, fortrinnsvis psykose, mer foretrukket schizofreni, i en tilleggsbehandling til minst ett antipsykotisk middel.The present invention is directed to the use of a class of peptide compounds for the prevention, alleviation and / or treatment of a disease which is treated with antipsychotic agents, preferably psychosis, more preferably schizophrenia, in an adjunctive treatment to at least one antipsychotic agent.

NO20074361A 2005-01-28 2007-08-27 Lacosamide for "add-on" therapy NO20074361L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64741005P 2005-01-28 2005-01-28
EP05001843A EP1688137A1 (en) 2005-01-28 2005-01-28 SPM 927 for add-on therapy of schizophrenia
PCT/EP2006/000722 WO2006079547A2 (en) 2005-01-28 2006-01-27 Spm 927 for add-on therapy of schizophrenia

Publications (1)

Publication Number Publication Date
NO20074361L true NO20074361L (en) 2007-10-26

Family

ID=36636204

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074361A NO20074361L (en) 2005-01-28 2007-08-27 Lacosamide for "add-on" therapy

Country Status (12)

Country Link
EP (1) EP1841417A2 (en)
JP (1) JP2008528532A (en)
KR (1) KR20070096058A (en)
AR (1) AR057643A1 (en)
AU (1) AU2006208630B2 (en)
BR (1) BRPI0607043A2 (en)
CA (1) CA2595330A1 (en)
EA (1) EA015566B1 (en)
IL (1) IL183973A0 (en)
MX (1) MX2007009070A (en)
NO (1) NO20074361L (en)
WO (1) WO2006079547A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1873527A1 (en) 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
EP1920780A1 (en) * 2006-10-12 2008-05-14 Schwarz Pharma Ag Peptide compounds for the treatment of hyperexcitability disorders
CN101466390B (en) 2006-06-15 2014-03-12 优时比制药有限公司 Pharmaceutical composition with synergistic anticonvulsant effect
US8735356B2 (en) * 2006-06-15 2014-05-27 Ucb Pharma Gmbh Anticonvulsant combination therapy
US20100260716A1 (en) 2007-10-23 2010-10-14 Ucb Pharma Gmbh Compounds for treating demyelination conditions
WO2010077916A1 (en) * 2008-12-16 2010-07-08 Eurand, Inc. Compositions comprising melperone
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide
EP3766485A1 (en) 2010-12-02 2021-01-20 UCB Pharma GmbH Once daily formulation of lacosamide
EP3558276A1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
EP3338768B1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine
CA3067938A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer
MX2020005517A (en) 2017-12-05 2020-11-09 Sunovion Pharmaceuticals Inc Crystal forms and production methods thereof.
CN112118838A (en) 2017-12-05 2020-12-22 赛诺维信制药公司 Non-racemic mixtures and uses thereof
KR20210022656A (en) 2018-06-20 2021-03-03 에르테에스 로만 테라피-시스테메 아게 Transdermal treatment system containing acenapine
JP2022535893A (en) 2019-06-04 2022-08-10 サノビオン ファーマシューティカルズ インク MODIFIED RELEASE FORMULATIONS AND THEIR USE
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
US5773475A (en) 1997-03-17 1998-06-30 Research Corporation Technologies, Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1243262B1 (en) 2001-03-20 2006-05-31 Schwarz Pharma Ag Novel use of a peptide class of compound for treating non-neuropathic inflammatory pain
EP1243263B1 (en) 2001-03-21 2002-11-27 Schwarz Pharma Ag Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain

Also Published As

Publication number Publication date
JP2008528532A (en) 2008-07-31
AU2006208630A1 (en) 2006-08-03
MX2007009070A (en) 2007-09-12
WO2006079547A3 (en) 2006-09-21
EA015566B1 (en) 2011-10-31
BRPI0607043A2 (en) 2009-08-04
WO2006079547A2 (en) 2006-08-03
KR20070096058A (en) 2007-10-01
AU2006208630B2 (en) 2011-09-29
AR057643A1 (en) 2007-12-12
IL183973A0 (en) 2008-12-29
EP1841417A2 (en) 2007-10-10
CA2595330A1 (en) 2006-08-03
EA200701594A1 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
NO20074361L (en) Lacosamide for "add-on" therapy
HK1121440A1 (en) Biphenyl derivatives and their use in treating hepatitis c
UY29112A1 (en) DERIVATIVES OF CONDENSED PIRAZOL, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION
GB0225475D0 (en) Therapeutic agents
GB0225474D0 (en) Therapeutic agents
GB0108592D0 (en) Therapeutic agents
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
GB0223038D0 (en) Therapeutic compounds
BRPI0410711A (en) new compounds
MY147247A (en) Organic compounds and their uses
TW200724543A (en) Heterocyclic compounds and their uses as therapeutic agents
EA200802428A1 (en) COMBINATION OF AGENTS FOR BIOLOGICAL FIGHT AND NEMATOCIDES INCLUDING THE SEEDS COATING
MX2009006536A (en) Organic compounds and their uses.
ATE534391T1 (en) 3,11B-CIS-DIHYDROTETRABENAZINE FOR THE TREATMENT OF PSYCHOSES
HK1141231A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
GB0223040D0 (en) Therapeutic compounds
EA200600971A1 (en) APPLICATION OF SUBSTITUTED 2 - AMINOTHETRALINES FOR THE PREVENTION TREATMENT OF PARKINSON'S Disease
TW200637538A (en) Lacosamide for add-on-therapy
RS51069B (en) Use of oxycodone for treating visceral pain
MXPA03008635A (en) Cyano-substituted dihydropyrimidine compounds and their use to treat diseases.
ATE380188T1 (en) SUBSTITUTED QUINOLONES
BRPI0509667A (en) Substituted azaquinazolines with antiviral efficacy
DE60317935D1 (en) ALPHA AMINOAMIDE DERIVATIVES AS AGENTS AGAINST MIGRAINE
CY1106950T1 (en) S-TENATOPRAZOL Sodium Sodium Monohydrate and Protein Pump Suspension Application
GB0522908D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application